Cypress Capital Group Davita Inc. Transaction History

Cypress Capital Group

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$108.37 - $120.0 $201,459 - $223,080	-1,859 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$94.5 - $116.95 $175,675 - $217,410	1,859 New	1,859 $211,000
Q3 2021 Oct 12, 2021	SELL	$116.26 - $133.78 $193,456 - $222,609	-1,664 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$105.44 - $127.98 $175,452 - $212,958	1,664 New	1,664 $200,000
Q1 2021 Apr 14, 2021	SELL	$99.98 - $123.89 $250,649 - $310,592	-2,507 Closed	0 $0
Q4 2020 Jan 12, 2021	BUY	$82.82 - $117.4 $207,629 - $294,321	2,507 New	2,507 $294,000

662

74.4M

1.41M

1.82M

Ticker DVA
Exchange NYSE
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 91,300,000
Market Cap $15.1B
Description
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine lab...

Get notified when there are updates to the investment portfolio of Cypress Capital Group, based on Form 13F filings with the SEC.

Stay updated on Cypress Capital Group with notifications on news.